Overview:

The Prostate Cancer Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis and staging, and an overview of treatments for localized disease, locally and regionally advanced disease, and metastatic disease. Dosing information is provided for LHRH agonists, anti-androgens, and chemotherapy. General information on sales of prostate cancer therapies worldwide, as well as for LHRH agonists and anti-androgens is provided.

Additional Information

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

I. OVERVIEW
General description of the condition

II. INCIDENCE, PREVALENCE AND MORTALITY
Trends in incidence and prevalence
Incidence Table (US, Canada, Argentina, Brazil, Mexico, UK, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, Japan, China, India, Philippines, Thailand, Egypt, South Africa, Americas, Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, Worldwide)
Prevalence Table (US, Canada, Mexico, UK, France, Germany, Italy, Spain, Japan, China, India, Worldwide)
Mortality Table (US, Canada, Argentina, Brazil, Mexico, UK, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, Japan, China, India, Philippines, Thailand, Egypt, South Africa, Americas, Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, Worldwide)

III. DIAGNOSIS AND STAGING
Symptoms
Tests
Staging

IV. TREATMENT
Localized disease
Locally and regionally advanced disease
Metastatic disease
Treatment rates

V. DOSING

VI. TREATMENT COSTS

VII. MARKET SIZE
Overall market size
Sales information for key pharmaceuticals

VIII. COMMENTS

IX. REFERENCES/RESOURCES